Page last updated: 2024-12-05

1-naphthylamine-5-sulfonic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-Naphthylamine-5-sulfonic acid, also known as **Cleve's acid**, is a chemical compound used in various research applications. It's a white to light brown solid, often found in its sodium salt form.

Here's why it's important for research:

* **Dye Industry:** Cleve's acid is a key intermediate in the production of **azo dyes**, a large class of synthetic dyes widely used in textiles, paper, and other industries. It provides a reactive functional group for coupling with diazonium salts, leading to the formation of colorful azo dyes.

* **Analytical Chemistry:** Due to its chromophoric properties, Cleve's acid can be used as a reagent for the **colorimetric determination of various substances.** It can react with specific compounds to produce colored solutions, allowing for quantitative analysis.

* **Pharmaceutical Research:** Cleve's acid has been explored as a starting material for the synthesis of **pharmaceutically active compounds.** Its structure can be modified to produce molecules with different pharmacological properties.

* **Materials Science:** Cleve's acid can be used in the **synthesis of polymers** and other materials with specific optical or electronic properties. Its sulfonic acid group contributes to the material's functionality.

* **Environmental Research:** Studies have investigated Cleve's acid as a potential **indicator of environmental pollution.** Its presence in water sources can be linked to industrial activities.

**However, it is crucial to note that:**

* 1-Naphthylamine-5-sulfonic acid is **classified as a possible human carcinogen.**
* Its use requires proper safety precautions and handling protocols.

Overall, 1-Naphthylamine-5-sulfonic acid remains a valuable tool in various scientific disciplines. Its versatility, reactivity, and unique properties make it relevant for diverse research applications.

1-naphthylamine-5-sulfonic acid: fluorophore used for fluorescent nucleotide substrates [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6793
CHEMBL ID589370
CHEBI ID183820
SCHEMBL ID147103
MeSH IDM0077647

Synonyms (56)

Synonym
1-aminonaphthalene-5-sulfonic acid
5-amino-1-naphthalenesulfonic acid
84-89-9
1-naphthalenesulfonic acid, 5-amino-
5-naphthylamine-1-sulfonic acid
laurent acid
1-amino-5-sulfonaphthalene
nsc7553
1-naphthylamine-5-sulfonic acid
1-amino-5-naphthalenesufonic acid
nsc-7553
nsc28691
nsc-28691
5-aminonaphthalene-1-sulphonic acid
nsc 28691
brn 2214149
einecs 201-571-0
5ns ,
5-aminonaphthalene-1-sulfonic acid
5-amino-1-naphthalenesulfonic acid, technical, >=90% (t)
AC-11003
laurent's acid
A0345
DB07176
CHEMBL589370 ,
1-amino-5-naphthalene sulfonate
bdbm50308731
CHEBI:183820
5-aminonaphthalene-1-sulonic acid
4-14-00-02800 (beilstein handbook reference)
w70wc365od ,
unii-w70wc365od
FT-0627716
FT-0619962
AKOS015902671
1-naphthylamine-5-sulfonic acid [mi]
5-sulfo-1-naphthylamine
SCHEMBL147103
DTXSID7058911
W-104099
1-amino-5-naphthalenesulfonic acid
STL481813
mfcd00014315
1-aminonaphthalene-5-sulphonic acid
1-aminonaphtalene-5-sulfonic acid
Q27096091
AS-17221
D88250
5-amin5-amino-1-naphthalenesulfonic acido-1-naphthalenesulfonic acid
A853491
EN300-123988
5-amino-1-naphthalenesulfonic acid, 90per cent
1-naphthylamine-5-sulfonic acid;laurent`s acid
PD005657
Z276161494
5-amino-1-naphthalenesulfonic acid, tech grade
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
naphthalenesulfonic acid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
TransthyretinHomo sapiens (human)Kd75.00000.00301.348210.0000AID456456; AID456457
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (2)

Processvia Protein(s)Taxonomy
signal transductionTransthyretinHomo sapiens (human)
purine nucleobase metabolic processTransthyretinHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (4)

Processvia Protein(s)Taxonomy
hormone activityTransthyretinHomo sapiens (human)
protein bindingTransthyretinHomo sapiens (human)
identical protein bindingTransthyretinHomo sapiens (human)
thyroid hormone bindingTransthyretinHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
extracellular regionTransthyretinHomo sapiens (human)
extracellular spaceTransthyretinHomo sapiens (human)
azurophil granule lumenTransthyretinHomo sapiens (human)
extracellular exosomeTransthyretinHomo sapiens (human)
extracellular spaceTransthyretinHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID456463Binding affinity to human recombinant TTR V30M mutant denominated hormone binding site expressed in Escherichia coli at 100 nM by fluorescence anisotropy2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Identification of a novel ligand binding motif in the transthyretin channel.
AID456464Binding affinity to human recombinant TTR T119M mutant denominated hormone binding site expressed in Escherichia coli at 100 nM by fluorescence anisotropy2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Identification of a novel ligand binding motif in the transthyretin channel.
AID456458Binding affinity to human recombinant TTR T119M mutant denominated hormone binding site expressed in Escherichia coli by FRET analysis2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Identification of a novel ligand binding motif in the transthyretin channel.
AID456462Binding affinity to wild type human TTR denominated hormone binding site expressed in Escherichia coli at 100 nM by fluorescence anisotropy2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Identification of a novel ligand binding motif in the transthyretin channel.
AID456456Binding affinity to human recombinant TTR V30M mutant denominated hormone binding site expressed in Escherichia coli by FRET analysis2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Identification of a novel ligand binding motif in the transthyretin channel.
AID456457Binding affinity to wild type human TTR denominated hormone binding site expressed in Escherichia coli by FRET analysis2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Identification of a novel ligand binding motif in the transthyretin channel.
AID456465Inhibition of wild type human TTR aggregation expressed in Escherichia coli assessed as fibril formation at 20 uM after 72 hrs relative by spectrofluorimetry2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Identification of a novel ligand binding motif in the transthyretin channel.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (50.00)18.7374
1990's3 (21.43)18.2507
2000's3 (21.43)29.6817
2010's1 (7.14)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.60 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.31 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]